| 申万期货品种策略日报——股指 | 2026/1/23 | 星期五 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 申银万国期货研究所 贾婷婷（从业资格号：F3056905；交易咨询号：Z0016232 ）jiatt@sywgqh.com.cn;15921620356 | 申银万国期货研究所 柴玉荣 （从业资格号：F03111639；交易咨询号：Z0018586）chaiyr@sywgqh.com.cn;18802979529 | | | | | | | | | | | 一、股指期货市场 | IF当月 | IF下月 | IF下季 | IF隔季 | | | | | | | | 前两日收盘价 | 4724.20 | 4722.80 | 4687.80 | 4632.00 | 前日收盘价 | 4722.00 | 4719.40 | 4683.00 | 4626.00 | | | 涨跌 | -8.40 | -9.20 | -8.00 | -7.60 | 沪深300 | 涨跌幅 | -0.1 ...

Core Viewpoint - The document outlines the government's initiative to promote high-quality development in the pharmaceutical retail industry through collaboration with commercial health insurance and the introduction of innovative insurance products to meet diverse consumer needs [1][2]. Group 1: Collaboration with Insurance - The government encourages the development of commercial health insurance products that align with pharmaceutical retail scenarios to meet the diverse protection needs of the public [1]. - It supports the establishment of risk-sharing and efficient payment mechanisms between pharmaceutical retail enterprises and commercial insurance institutions, specifically for high-value drugs and medical devices, to reduce patient payment burdens [1]. Group 2: Innovative Insurance Products - The document promotes the development of commercial health insurance products that include health management and elder care services [1]. - It also encourages insurance institutions to create liability insurance for drone delivery of medical supplies and equipment [2].

Core Viewpoint - The Ministry of Commerce and nine other departments have issued opinions to promote the high-quality development of the pharmaceutical retail industry, focusing on the establishment of a commercial insurance payment guarantee system [1] Group 1: Commercial Insurance Development - The initiative aims to guide the collaborative development of commercial health insurance and basic medical insurance [1] - It encourages insurance institutions to develop commercial health insurance products tailored to the pharmaceutical retail scenario, addressing diverse protection needs of the public [1] - The plan supports the launch of commercial health insurance products that include health management and elder care services [1] Group 2: Risk Sharing Mechanism - The initiative supports the establishment of a risk-sharing and efficient payment collaboration mechanism between pharmaceutical retail enterprises and commercial insurance institutions, particularly for high-value drugs and medical devices [1] - This mechanism is designed to effectively reduce the financial burden on patients [1]